Vorinostat Plus Lenalidomide and Dexamethasone or Lenalidomide Plus Dexamethasone in Multiple Myeloma Patients Who Experience Biochemical Relapse During Lenalidomide Maintenance Therapy (ZLd_Ld)

This study has been withdrawn prior to enrollment.
Sponsor:
Information provided by (Responsible Party):
Tiziana Marangon, University of Turin, Italy
ClinicalTrials.gov Identifier:
NCT01501370
First received: December 16, 2011
Last updated: December 10, 2013
Last verified: December 2013
No Study Results Posted on ClinicalTrials.gov for this Study
Study was withdrawn before participants were enrolled.
  Study Status: This study has been withdrawn prior to enrollment.
  Estimated Study Completion Date: February 2017
  Estimated Primary Completion Date: February 2014 (Final data collection date for primary outcome measure)